1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Belgium >
  5. Biotie Therapies Acquires elbion NV

M&A Deal Summary

Biotie Therapies Acquires elbion NV

On October 27, 2008, Biotie Therapies acquired life science company elbion NV

Acquisition Highlights
  • This is Biotie Therapies’ 1st transaction in the Life Science sector.
  • This is Biotie Therapies’ 1st transaction in Belgium.

M&A Deal Summary
Date 2008-10-27
Target elbion NV
Sector Life Science
Buyer(s) Biotie Therapies
Deal Type Add-on Acquisition

Target

elbion NV

Leuven, Belgium
elbion NV is a drug company focused on neurology and immunology.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Biotie Therapies

Turku, Finland
Category Company
Sector Life Science
Employees39
Revenue 15M EUR (2014)
DESCRIPTION

Biotie Therapies Corp. is a biopharmaceutical company primarily focused on developing therapeutics for central nervous system disorders. Its pipeline includes product candidates designed to address unmet medical needs in Parkinson’s disease and related dementia, other neurodegenerative indications and primary sclerosing cholangitis, an orphan fibrotic liver disease.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Belgium M&A 1 of 1
Year: 2008 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal